Adjuvant Capital

Venture Capital Exempt reporting adviser

Legal name: Adjuvant Capital, LP

New York, NY Website LinkedIn X

AUM

$170.1M
Private fund assets

Private funds

2
Venture Capital 2

Private fund assets

$170.1M
Gross asset value

Employees

—

Last Form D raise

Feb 2021
Most recent fund filing

From SEC Form ADV filing (filed Mar 27, 2026). View on SEC

People(3)

Owners and executive officers named on the firm's SEC Form ADV.

E
Evelyn Yanatos
Director of Finance and Compliance; Chief Compliance Officer
Source: SEC Form ADV
G
Glenn Rockman
Managing Partner
Source: SEC Form ADV
K
Kabeer Aziz
Partner
Source: SEC Form ADV

Funds(2)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Adjuvant Global Health Technology Fund, L.P.Venture Capital$143.2M$251.8M21Feb 2021Cold
Adjuvant Global Health Technology Fund De, L.P.Venture Capital$26.9M$48.2M14Feb 2021Cold

Board seats

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

No board seats matched from SEC filings yet.

Regulatory identifiers

CRD number
301716
SEC file number
802-129182

Sources